Sharmiashvili NI, Garrido SA

Language: Spanish
References: 13
Page: 137-140
PDF size: 613.57 Kb.

ABSTRACT

Castleman disease is a rare linphoproliferative disorder characterized by growth of lymphatic tissue tumors. Most frequently, the Castleman disease is found in the mediastinum, stomach and neck. There are four histological types: vascular hyaline type, plasmatic cell type, and recently discovered multicentric type not otherwise specified and Castleman desease associated to herpes virus 8. Clinical case: 38 years old woman arrives to our hospital with epigastralgia which has been present for a year. Abdominal computeraized tomography: pancreatic head with pseudonodular formation, and prominent adenopathies at retroperitoneal, mesenteric and pelvic zone. Magnetic resonance imaging: pancreatic tumor of approximately 4 cm, adjacent to the duodenal knee with different diagnostic possibilities. The surgery was performed by right subcostal laparotomy, in which the tumoration adjacent to pancreatic tissue was completely removed. Patient evolved favorably, and at the monitoring stayed asymptomatic. Transoperatory biopsy of the pathological anatomy and of the surgical piece showed pancreatic tissue in continuity with lymphoid issue with Castleman disease, vascular hyaline type. Discussion: According to the consulted bibliography and our case the only curative treatment in vascular hyaline type of Castleman disease is surgical removal of the lesion and its adenopathies.

REFERENCES

1. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer. 1956; 9 (4): 822-830.

2. Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Burt ME et al. The management of unicentric and multicentric Castleman’s disease: a report of 16 cases and a review of the literature. Cancer. 1999; 85 (3): 706-717.

3. Talat N, Schulte KM. Castleman’s disease: systematic analysis of 416 patients from the literature. Oncologist. 2011; 16 (9): 1316-1324.

4. Cronin DM, Warnke RA. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol. 2009; 16 (4): 236-246.

5. Bonekamp D, Horton KM, Hruban RH, Fishman EK. Castleman disease: the great mimic. Radiographics. 2011; 31 (6): 1793-1807.

6. Zapata-Bonilla SA, López-Vargas R, Scherling-Ocampo AA, Morales-Leyte AL, García-Ilizaliturri L. Enfermedad de Castleman Multicéntrica tipo hialino-vascular en paciente inmunocompetente. Gac Méd Méx. 2015; 151 (5): 648-654.

7. Peterson BA, Frizzera G. Multicentric Castleman’s disease. Semin Oncol. 1993; 20 (6): 636-647.

8. Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol. 2005; 129 (1): 3-17.

9. Waterston A, Bower M. Fifty years of multicentric Castleman’s disease. Acta Oncol. 2004; 43 (8): 698-704.

10. Debatin JF, Spritzer CE, Dunnick NR. Castleman disease of the adrenal gland: MR imaging features. AJR Am J Roentgenol. 1991; 157 (4): 781-783.

11. Johkoh T, Müller NL, Ichikado K, Nishimoto N, Yoshizaki K, Honda O et al. Intrathoracic multicentric Castleman disease: CT findings in 12 patients. Radiology. 1998; 209 (2): 477-481.

12. Bonini C, Boretti JJ, Villavicencio R, Oxilia H, Costamagna C, Ferrer J et al. Enfermedad de Castleman de localización retroperitoneal (peripancreática): hallazgos imagenológicos. Rev Argent Radiol. 2003; 67 (4): 377-383.

13. Mondragón J, Jiménez P, Alvaradi R, Páez C, Gallego J. Enfermedad de Castellana peripancreática. Presentación de un caso y revisión de la literatura. Acta Padiatr Mex. 2005; 26 (2): 96-99.